Neuroscience-informed auditory training in schizophrenia: A final report of the effects on cognition and serum brain-derived neurotrophic factor

Schizophrenia Research: Cognition

Volumn 3, Issue , 2016, Pages 1-7

  Fisher, Melissa ^a,b   Mellon, Synthia H ^a   Wolkowitz, Owen ^a   Vinogradov, Sophia ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BDNF; Cognitive remediation; Neuroplasticity; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; COGNITION; COGNITIVE REMEDIATION THERAPY; DOUBLE BLIND PROCEDURE; DSM-IV; EXERCISE; FEMALE; HEARING; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; POSITIVE AND NEGATIVE SYNDROME SCALE; PROBLEM SOLVING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TRAINING; VERBAL MEMORY; VIDEO GAME; VISUAL MEMORY;

EID: 84959372169     PISSN: 22150013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scog.2015.10.006     Document Type: Article

References (42)

1. Adcock A., Dale C., Fisher M., Aldebot S., Genevsky A., Simpson G., Nagarajan S., Vinogradov S. When Top-down meets bottom-Up: Auditory training enhances verbal memory in schizophrenia. Schizophr. Bull. 2009, 35(6):1132-1141.
2. Ahmed A.O., Mantini A.M., Fridberg D.J., Buckley P.F. Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis. Psychiatry Res. 2015, 226:1-13.
3. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.-C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010, 67:255-262.
4. Angelucci F., Peppe A., Carlesimo G.A., Serafini F., Zabberoni S., Barban F., Shofany J., Caltagirone C., Costa A. A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson's disease. Front. Hum. Neurosci. 2015, 16(9):130.
5. Anomal R., de Villers-Sidani E., Merzenich M.M., Panizzutti R. Manipulation of BDNF signaling modifies the experience-dependent plasticity induced by pure tone exposure during the critical period in the primary auditory cortex. PLoS One 2013, 21:8(5).
6. Bilker W.B., Brensinger C., Kurtz M.M., Kohler C., Gur R.C., Siegel S.J., Gur R.E. Development of an abbreviated Schizophrenia Quality of Life Scale using a new method. Neuropsychopharmacology 2003, 28:773-777.
7. Buckley P.F., Mahadik S., Pillai A., Terry A. Neurotrophins and schizophrenia. Schizophr. Res. 2007, 94:1-11.
8. Carlino D., De Vanna M., Tongiorgi E. Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?. Neuroscientist 2012, 19(4):345-353.
9. Dale C.L., Findlay A.M., Adcock R.A., Vertinski M., Fisher M., Genevsky A., Aldebot S., Subramaniam K., Luks T.L., Simpson G.V., Nagarajan S.S., Vinogradov S. Timing is everything: Neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects. Int. J. Psychophysiol. 2010, 75(2):183-193.
10. Deci EL E.H., Patrick B.C., Leone D. Facilitating internalization: The self-determination theory perspective. J. Pers. 1994, 62:119-142.
11. Dworak M., Schierl T., Bruns T., et al. Impact of singular excessive computer game and television exposure on sleep patterns and memory performance of school-aged children. Pediatrics 2007, 120(5):978-985.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
13. Fisher M., Holland C., Merzenich M., Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am. J. Psychiatr. 2009, 166:805-811.
14. Fisher M., Holland C., Subramaniam K., Vinogradov S. Neuroplasticity-based cognitive training: What are the effects 6-months later?. Schizophr. Bull. 2010, 36(4):869-879.
15. Fisher M., Loewy R., Carter C., Lee A., Ragland J.D., Niendam T., Schlosser D., Pham L., Miskovich T., Vinogradov S. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophr. Bull. 2015, 41(1):250-258.
16. Green M.F., Kern R.S., Heaton R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 2004, 72(1):41-51.
17. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol. Psychiatry 2011, 16:960-972.
18. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 1984, 10(3):388-398.
19. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 2002, 328:261-264.
20. Kasai K., Nakagome K., Itoh K., Koshida I., Hata A., Iwanami A., Fukuda M., Kato N. Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: a high-resolution event-related potential study. Am. J. Psychiatry 2002, 159(4):546-553.
21. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
22. Keefe R.S., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 2004, 68(2-3):283-297.
23. Keefe R.S.E., Vinogradov S., Medalia A., Buckley P.F., Caroff S.N., D'Souza D.C., Harvey P.D., Graham K.A., Hamer R.M., Marder S.M., Miller D.D., Olson S.J., Patel J.K., Velligan D., Walker T.M., Haim A.J., Stroup T.S. Feasibility and pilot efficacy results from the multi-site Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) study. J. Clin. Psychiatry 2012, 73:1016-1022.
24. Khalin I., Alyautdin R., Kocherga G., Bakar M.A. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int. J. Nanomedicine 2015, 10:3245-3267.
25. Kimhy D., Vakhrusheva J., Bartels M.N., Armstrong H.F., Ballon J.S., Khan S., Chang R.W., Hansen M.C., Ayanruoh L., Lister A., Castrén E., Smith E.E., Sloan R.P. The impact of aerobic exercise on brain-derived Neurotrophic factor and neurocognition in individuals with schizophrenia: A single-blind, randomized clinical trial. Schizophr. Bull. 2015, 41(4):859-868.
26. Lang U.E., Hellweg R., Seifert F., Schubert F., Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 2007, 62:530-535.
27. Mao Y.T., Hua T.M., Pallas S.L. Competition and convergence between auditory and cross-modal visual inputs to primary auditory cortical areas. Neurophysiology 2011, 105(4):1558-1573.
28. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 2007, 164(12):1791-1802.
29. McGurk S.R., Mueser K.T., Xie H., Welsh J., Kaiser S., Drake R.E., Becker D.R., Bailey E., Fraser G., Wolfe R., McHugo G.J. Cognitive enhancement treatment for people with mental illness Who Do Not respond to supported employment: A randomized controlled trial. Am. J. Psychiatry 2015, 172(9):852-861.
30. Murthy N.V., et al. Computerized cognitive remediation training for schizophrenia: an open label, multi-site, multinational methodology study. Schizophr. Res. 2012, 139:87-91.
31. Nuechterlein K.H., Green M.F. MATRICS Consensus Cognitive Battery Manual 2006, MATRICS Assessment, Inc., Los Angeles.
32. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
33. Pillai A., Kale A., Joshi S., Naphade N., Raju M.S., Nasrallah H., et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int. J. Neuropsychopharmacol. 2010, 13:535-539.
34. Piskulic D., Barbato M., Liu L., Addington J. Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Psychiatry Res. 2015, 225:93-98.
35. Popov T., Jordanov T., Rockstroh B., et al. Specific cognitive training normalizes auditory sensory gating in schizophrenia: a randomized trial. Biol. Psychiatry 2011, 69(5):465-471.
36. Pressler S.J., Titler M., Koelling T., Riley P.L., Jung M., Hoyland-Domenico L., Ronis D.L., Smith D.G., Bleske B.E., Dorsey S.G., Giordani B. Nurse-enhanced computerized cognitive training increases serum brain-derived Neurotrophic factor levels and improves working memory in heart failure. J. Card. Fail. 2015, 8:630-641.
37. Ragland J.D., Gur R.C., Valdez J., Turetsky B.I., Elliott M., Kohler C., Siegel S., Kanes S., Gur R.E. Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am. J. Psychiatry 2004, 161(6):1004-1015.
38. Ragland J.D., Moelter S.T., Bhati M.T., Valdez J.N., Kohler C.G., Siegel S.J., Gur R.C., Gur R.E. Effect of retrieval effort and switching demand on fMRI activation during semantic word generation in schizophrenia. Schizophr. Res. 2007, 99(1-3):312-323.
39. Ryan R., Koestner R., Deci E.L. Ego-involved persistence: When free-choice behavior is not intrinsically motivated. Motiv. Emot. 1991, 15:185-205.
40. Subramaniam K., Luks T., Fisher M., Simpson G.V., Nagarajan S., Vinogrdov S. Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron 2012, 73(4):842-853.
41. Vinogradov S., Fisher M., Holland C., Shelly W., Wolkowitz O., Mellon S.H. Is serum BDNF a biomarker for cognitive enhancement in schizophrenia?. Biol. Psychiatry 2009, 66(6):549-553.
42. Wykes T., Huddy V., Cellard C., et al. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168(5):472-485.